Skip to content

Yuta Takahashi

Department of Information Medicine, National Center of Neurology and Psychiatry, Tokyo, Japan. ytakaha@ncnp.go.jp.

2 papers in the library · 21 citations · publishing 2025-2026

Papers

Digital twin brain simulator for real-time consciousness monitoring and virtual intervention using primate electrocorticogram data.

NPJ digital medicine February 10, 2025 Yuta Takahashi, Hayato Idei, Misako Komatsu et al. 21 citations

A real-time electrocorticogram (ECoG) simulator based on a digital twin brain concept was developed. Using a Variational Bayesian Recurrent Neural Network with hierarchical latent units, the model dynamically predicted ECoG signals by assimilating data from macaque monkeys in awake and anesthetized conditions. The model updated its latent states in real-time, improving simulation precision. Self-organization of latent states reflected brain states and individuality, enabling simulation of virtual drug administration and revealing functional networks underlying anesthesia-induced changes. The simulator achieves high-accuracy real-time brain signal simulation and helps uncover underlying information processing dynamics.

Effects of 4-position substitutions of diphenidine on blood-brain barrier penetration and dopamine release in the nucleus accumbens of rats.

Forensic toxicology July 1, 2026 Yuta Takahashi, Katsuhiro Okuda, Kazuo Matsubara et al.

Diphenidine (DPD) and its analogues 4-methoxydiphenidine (4MeO-DPD) and 4-hydroxydiphenidine (4OH-DPD) all penetrate the blood-brain barrier and trigger dopamine release in rats. 4OH-DPD produced the highest brain concentrations and dopamine release. Pretreatment with verapamil, a P-glycoprotein inhibitor, increased brain levels and prolonged elimination of all compounds, especially 4MeO-DPD, indicating that P-glycoprotein normally restricts their brain entry. Diphenhydramine, an organic cation transporter inhibitor, had no effect. The findings suggest that P-glycoprotein activity is a key factor in the toxicological risk of these emerging novel psychoactive substances.